Brain development is critically dependent on thyroid hormone (T 3 ). Krü ppel-like factor 9 (Klf9) is a T 3 -inducible gene in developing rat brain, and several lines of evidence support that KLF9 plays a key role in neuronal morphogenesis. Here we extend our findings to the mouse and demonstrate the presence of a functional T 3 response element (T 3 RE) in the 5Ј flanking region of the mouse Klf9 gene. Klf9 mRNA is strongly induced in the mouse hippocampus and cerebellum in a developmental stage-and T 3 -dependent manner. Computer analysis identified a near optimal direct repeat 4 (DR-4) T 3 RE 3.8 kb upstream of the Klf9 transcription start site, and EMSAs showed that T 3 receptor (TR)-retinoid X receptor heterodimers bound to the T 3 RE with high affinity. The T 3 RE acts as a strong positive response element in transfection assays using a minimal heterologous promoter. In the mouse neuroblastoma cell line N2a T hyroid hormone deficiency during the period of active neurogenesis (up to 6 months postpartum) results in irreversible mental retardation (i.e. cretinism) that is associated with multiple morphological alterations in the brain (1, 2). Thyroid hormone exerts pleiotropic actions on the developing brain, influencing diverse processes such as neuronal maturation, neurite outgrowth, synapse formation, cell proliferation, timing of cell differentiation, and myelination (2). Hypothyroidism during fetal and neonatal life results in abnormal axonal development and greatly reduced dendritic arborization in specific cell populations (3-7). Krü ppel-like factor 9 (Klf9; also basic transcription element binding protein 1) (8), a member of the specificity protein/ Krü ppel-like family of zinc-finger domain transcription factors (9, 10), is strongly induced by T 3 in the developing brain of frog (11, 12) and rat (13). KLF9 plays a key role in thyroid hormone-dependent actions on neurite extension and branching (13-15), and Morita et al. (16) showed that disruption of the mouse Klf9 locus resulted in reduced dendritic arborization in cerebellar Purkinje cells and behavioral deficits consistent with abnormal functions of the amygdala, hippocampus, and cerebellum.
Brain development is critically dependent on thyroid hormone (T 3 ). Krü ppel-like factor 9 (Klf9) is a T 3 -inducible gene in developing rat brain, and several lines of evidence support that KLF9 plays a key role in neuronal morphogenesis. Here we extend our findings to the mouse and demonstrate the presence of a functional T 3 response element (T 3 RE) in the 5Ј flanking region of the mouse Klf9 gene. Klf9 mRNA is strongly induced in the mouse hippocampus and cerebellum in a developmental stage-and T 3 -dependent manner. Computer analysis identified a near optimal direct repeat 4 (DR-4) T 3 RE 3.8 kb upstream of the Klf9 transcription start site, and EMSAs showed that T 3 receptor (TR)-retinoid X receptor heterodimers bound to the T 3 RE with high affinity. The T 3 RE acts as a strong positive response element in transfection assays using a minimal heterologous promoter. In the mouse neuroblastoma cell line N2a T hyroid hormone deficiency during the period of active neurogenesis (up to 6 months postpartum) results in irreversible mental retardation (i.e. cretinism) that is associated with multiple morphological alterations in the brain (1, 2) . Thyroid hormone exerts pleiotropic actions on the developing brain, influencing diverse processes such as neuronal maturation, neurite outgrowth, synapse formation, cell proliferation, timing of cell differentiation, and myelination (2) . Hypothyroidism during fetal and neonatal life results in abnormal axonal development and greatly reduced dendritic arborization in specific cell populations (3) (4) (5) (6) (7) . Krü ppel-like factor 9 (Klf9; also basic transcription element binding protein 1) (8) , a member of the specificity protein/ Krü ppel-like family of zinc-finger domain transcription factors (9, 10) , is strongly induced by T 3 in the developing brain of frog (11, 12) and rat (13) . KLF9 plays a key role in thyroid hormone-dependent actions on neurite extension and branching (13) (14) (15) , and Morita et al. (16) showed that disruption of the mouse Klf9 locus resulted in reduced dendritic arborization in cerebellar Purkinje cells and behavioral deficits consistent with abnormal functions of the amygdala, hippocampus, and cerebellum.
Several lines of evidence suggest that Klf9 is a direct thyroid hormone response gene. For example, T 3 induction of Klf9 in the mouse-derived neuroblastoma cell line N2a[TR␤1] (17) is resistant to protein synthesis inhibition, and nuclear run-on analysis showed that T 3 increased the rate of Klf9 transcription (13) . The immediate early kinetics of Klf9 gene regulation in mammalian and frog cells supports direct transactivation by liganded thyroid hormone receptor (TR) (13, 18, 19) . These actions are likely mediated by one or more thyroid hormone response elements (T 3 REs) present in the Klf9 gene. Furlow and Kanamori (18) demonstrated the presence of a direct repeat 4 (DR-4) T 3 RE in the Xenopus laevis Klf9 5Ј flanking region.
In the present study, we investigated the molecular basis for T 3 regulation of the Klf9 gene in developing mouse brain. We first confirmed that Klf9 is developmentally regulated and induced by T 3 in the mouse brain as we earlier found it to be in the rat (13) . We next analyzed the mouse Klf9 gene and its 5Ј flanking region for the presence of putative T 3 REs. We identified a near optimal DR-4 T 3 RE located about 3.8 kb upstream of the transcription start site. Using EMSA, in vitro transfection assay and chromatin immunoprecipitation (ChIP) assay, we tested whether this DR-4 T 3 RE was functional in both cell culture using N2a[TR␤1] cells and neonatal mouse brain in vivo.
Materials and Methods

Animals
Wild-type C57BL/6j mice were purchased from Jackson Laboratories (Bar Harbor, ME) and bred in the laboratory. Animals were euthanized and brain tissue harvested at different postnatal days for gene expression analyses. For gene expression analyses and ChIP assays neonatal mice [postnatal day (P) 4] were given ip injections of saline or 3,5,3Ј triiodothyronine (T 3 sodium salt; 25 g/kg body weight; Sigma, St. Louis MO), euthanized 4 h later, and blood plasma and brain tissue harvested for analysis. All procedures were conducted in accordance with guidelines of The University of Michigan Committee on the Care and Use of Animals.
RNA isolation and gene expression analysis by quantitative, real-time RT-PCR
We extracted RNA from microdissected mouse brain sections that contained either the hippocampus or cerebellum or from N2a[TR␤1] cells using the Trizol reagent (Invitrogen, Carlsbad, CA) following the manufacturer's instructions. The RNA was treated with deoxyribonuclease I and ribonuclease inhibitor before cDNA synthesis with Superscript II (Invitrogen) using random hexamers (Applied Biosystems, Foster City, CA). TaqMan assays (Applied Biosystems) were used to quantify transcripts for Klf9 and the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH). For Klf9 we designed a custom TaqMan assay to span the exon/exon boundary (Klf9 has two exons and a single intron; supplemental Table 1 , published as supplemental data on The Endocrine Society's Journals Online web site at http://endo. endojournals.org). The mouse hr and GAPDH assays were purchased from Applied Biosystems. A relative quantification method (see Refs. 20 and 21) was used to compare gene expression levels by generating standard curves for each gene with a pool of cDNAs. Klf9 and hr mRNA expression were normalized to GAPDH mRNA, which did not vary significantly across developmental stages or among treatments.
Sequence analysis and plasmid constructs
We searched for putative T 3 RE half-sites in the mouse Klf9 gene encompassing 10 kb upstream of the transcription start site, the two exons, and single intron using several online computer programs including MatInspector (version 7.7.3.1, Matrix library version 8.0; Genomatix Software GmbH, Munich, Germany), TFSEARCH version 1.3 (searches the TFMATRIX transcription factor binding site profile database by E. Wingender, R. Knueppel, P. Dietze, H. Karas; GBF-Braunschweig, Braunschweig, Germany) and PROMO using version 8.3 of TRANS-FAC (22, 23) . We also used the sequence analysis program Vector NTI Suite version 10 (Invitrogen) to conduct user-defined searches. Putative T 3 RE half-sites identified in this manner were examined for neighboring half-sites consistent with DR-4, inverted palindrome (IP), or palindrome configurations (24) . After identifying potential T 3 REs, we next used a comparative genomic approach to further score DNA sequences for functional analysis. Portions of the mouse Klf9 genomic region were aligned with rat and human genome sequences using CLUSTALW analysis in the Vector NTI Suite AlignX module (version 10; Invitrogen). Only those sequences that were conserved with rat or human or both (Ͼ50% identity) were considered for further analysis.
Oligonucleotides for native and mutant sequences based on the putative T 3 REs were synthesized for use in EMSA or for generating plasmid constructs for transfection assay (see below; supplemental Table 2 ). For tests of the functionality of putative T 3 RE sequences, constructs were generated using the pGL3 promoter plasmid (Promega, Inc., Madison, WI). Oligonucleotide duplexes were directionally cloned into the KpnI and NheI sites of pGL3promoter to generate pGL3-Klf9[DR-4T 3 RE] (corresponding to the DR-4 T 3 RE located at ϳ3.8 kb upstream of the transcription start site; see Table 1 ) and pGL3-Klf9[DR-4T 3 REmt] (a mutated DR-4 T 3 RE located ϳ3.8 kb upstream of the transcription start site; see supplemental Table 2 ). The ptkDR-4Luc plasmid contains the rat growth hormone T 3 RE and was a gift of Ronald Koenig (University of Michigan, Ann Arbor, MI).
EMSA
We conducted EMSA as described by Hoopfer et al. (12) with recombinant TR␣, TR␤, and retinoid X receptor (RXR)-␣ produced in vitro using the TnT SP6 quick-coupled translation system (Promega) following the manufacturer's instructions. 
Cell culture and transfection assay
We used the mouse neuroblastoma cell line Neuro-2a that was engineered to express TR␤1 [N2a (TR␤1); 17] to investigate gene expression and TR association and chromatin modifications at putative T 3 REs in the mouse genome. This cell line was previously shown to up-regulate Klf9 mRNA after T 3 treatment (13). Cells were plated at a density of 0.5 ϫ 10 6 cells/well in six-well plates for gene expression analyses, 1 ϫ 10 5 cells/well in 24-well plates for transfection assays, or 2.5 ϫ 10 6 in 100-mm tissue culture dishes for ChIP assays and cultured overnight before transfections or hormone treatments. Cells were cultured at 37 C in an atmosphere of 5% CO2-95% air in 50:50 DMEM-Hams F12 containing 500 g/ml hygromycin B, penicillin G sodium (100 U/ml), streptomycin sulfate (100 g/ml), and 10% thyroid hormone-stripped (25) fetal bovine serum (Invitrogen). For gene expression analyses in N2a[TR␤1] cells, the growth medium was changed to serum-free DMEM-F12 and cells were treated with T 3 for 6 h before harvest and RNA isolation.
For luciferase reporter assay experiments, we transfected cells with enhancer-reporter plasmids (200 ng DNA per well) using the FuGene 6 transfection reagent (Roche, Indianapolis, IN) following the manufacturer's instructions. All cells were cotransfected with the pRenilla-luciferase plasmid (10 ng/well; Promega) for normalization of cell transfection by dual-reporter luciferase assay following the manufacturer's instructions (Promega). Immediately before transfection the cells were washed twice with serum-free DMEM-F12. After 1 h the transfection medium was replaced with growth medium and the cells were incubated overnight. Cells were then treated with or without T 3 for different times before harvest and analysis of luciferase activity. Luciferase activity was quantified (measured as relative light units) using a luminometer (Femtomater FB 12; Zylux Corp., Maryville, TN). Each transfection experiment was conducted four times with three to six wells per treatment.
ChIP assay
We conducted ChIP assays on chromatin extracted from tissue culture cells and mouse brain following methods described previously with slight modifications (26, 27) . We used the ChIP assay kit (Upstate Biotechnology, Inc., Lake Placid, NY) following the manufacturer's instructions. To cross-link nuclear proteins, cells or brain lysates were treated with the homobifunctional cross-linking agent dithiobis[succinimidyl propionate] (DSP; Pierce Chemical Co., Rockford, IL) (28) . Cells in 100-mm dishes were washed with Dulbecco's PBS [DPBS (pH 7.4); Invitrogen], 10 ml of DPBS were added, and a 25-mM solution of DSP dissolved in dimethyl sulfoxide was added dropwise to a final concentration of 0.2 mM. The cells were incubated for 15 min at room temperature, the medium removed, and the cells washed with DPBS before proceeding to formaldehyde cross-linking. For the mouse brain, 0.3-0.5 mg of tissue was homogenized using a Dounce homogenizer in 0.75 ml nuclei extraction buffer [0.5% Triton X-100, 10 mM Tris-HCl, (pH 7.5), 3 mM CaCl 2 , 0.25 M sucrose, 1 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl fluoride, and 1ϫ protease inhibitor cocktail; Sigma-Aldrich]. The stock DSP solution was added dropwise to a final concentration of 0.2 mM, and the samples were incubated at room temperature with rotation for 20 min. The samples were centrifuged at 2000 ϫ g at 4 C for 2 min and the pellets washed with DPBS and resuspended in 1 ml nuclei extraction buffer. Twenty-five microliters of 37% formaldehyde were added to cross-link proteins to DNA.
The chromatin extraction procedure and DNA shearing by sonication were optimized for N2a[TR␤1] cells and mouse brain tissue. For DNA shearing by sonication, we used a sonic dismembrator 100 (Fisher, Fair Lawn, NJ). N2a[TR␤1] cells were harvested from 100-mm dishes and the cell lysates were sonicated for five cycles of 10 sec each at an output rating of 5-6 watts. For mouse brain tissue lysates, we used 10 cycles of 10 sec each at an output rating of 5-6 watts. Cell and tissue lysates were maintained on ice during the sonication procedure.
For ChIP assay we used a rabbit polyclonal antiserum raised against the full-length Xenopus laevis TR␤ (PB antiserum provided by Yun-Bo Shi; National Institute of Child Health and Development, National Institutes of Health, Bethesda, MD). This antiserum has been used extensively for ChIP assay on frog tissues (e.g. Refs. 26, 29, 30) , and the frog and mouse TR proteins share greater than 90% sequence identity. This antiserum does not distinguish TR␣ from TR␤. For acetylated histones 3 (acH3) and 4 (acH4), we used polyclonal antisera (Upstate Biotechnology; ␣-acH3, catalog no. 06-599; ␣-acH4 cat. no. 06-598; Upstate Biotechnology). To determine nonspecific binding (NSB), we either used straight normal rabbit serum (NRS; Sigma-Aldrich; for experiments with the PB antiserum) or we purified the IgG from NRS using a protein A column following the manufacturer's instructions (Pierce; for acetylated histones). The degree of enrichment in the ChIP assay for anti-TR relative to the NRS varied, depending on the treatment (ϮT 3 ) and the genomic region analyzed and ranged from about 1.5-to 7-fold. For anti-acH3 or anti-acH4, the degree of enrichment ranged from about 30-to greater than 350-fold. Negative controls for the ChIP assays included the omission of primary antibody (which uniformly produced no signal; data not shown), replacement of the primary antibody with NRS (straight or purified IgG), and the analysis of regions outside of the predicted T 3 RE regions (the proximal Klf9 promoter, the medial intron at 11.5 kb downstream of the transcription start site). ChIP samples were analyzed by real-time quantitative PCR using TaqMan assays (supplemental Table  2 ). Standard curves were constructed using a pool of input samples, and each ChIP sample was normalized to its respective input.
Data analysis and statistics
Data were analyzed by one-way ANOVA or t test using the SYSTAT computer program (version 10; SPSS Inc., Chicago, IL). Data were log 10 transformed if the variance was found to be heterogeneous by Bartlett's test. Percentages are shown in the figures; percentages were arcsine transformed before statistical analysis. P Ͻ 0.05 was accepted as statistically significant. Gene expression data are reported as the mean Ϯ SEM. hr mRNA expression was elevated at P4]. Intraperitoneal injection of T 3 in P4 mice increased Klf9 and hr mRNAs in hippocampus and cerebellum ( Fig. 1C ; Klf9-hippocampus: P ϭ 0.002; cerebellum: P ϭ 0.001; Fig. 1D ; hr-hippocampus: P ϭ 0.007; cerebellum: P ϭ 0.006; t test).
Results
Klf9
The mouse Klf9 gene has a DR-4 T 3 RE about 3.8 kb upstream of the transcription start site We identified a near optimal DR-4 T 3 RE at 3.8 kb upstream of the predicted transcription start site of the mouse Klf9 gene by computer analysis. The sequence of this T 3 RE, and comparison with other known and predicted T 3 REs are shown in Table 1 , and its relative position in the mouse Klf9 locus is shown in Fig.  2A . MatInspector (Genomatix Software) identified this T 3 RE with a matrix similarity score of 0.971; a score of 1.0 is a perfect score, whereas 0.8 is considered a good score. This was the only T 3 RE identified by this program within the 5Ј flanking region of the gene. The other search programs that we used also identified this site. Putative DR-4 T 3 REs are also present in the rat and human Klf9 genes in homologous locations of their respective genomes (200 bp segment encompassing the T 3 RE: rat, 84% identity; human, 70% identity; Table 1 ). For comparison, 5 kb of the 5Ј flanking regions upstream of the transcription start sites of the rat and human Klf9 genes share 75 and 70% sequence identity, respectively, with the mouse gene. The proximal promoters (500 bp) of the rat and human Klf9 genes share 97 and 85%, respectively, with the mouse gene. We located a potential inverted palindrome T 3 RE with half-sites spaced by four nucleotides (IP-4) in the mouse Klf9 intron at ϩ5.2 kb. This genomic region (200 bp encompassing the putative T 3 RE) is conserved in the rat (91%) and human (82%) genes. For comparison, the entire introns of the rat and human Klf9 genes share 84 and 59% sequence identity, respectively, with the mouse gene.
EMSA showed that TR-RXR heterodimers bound to the mouse Klf9 T 3 RE (Fig. 2, B and C). The binding of both TR␣-RXR␣ and TR␤-RXR␣ heterodimers was reversible and of high affinity; TR monomers or homodimers did not bind. Binding of the protein complexes to the Xenopus TR␤ T 3 RE (xT 3 RE) is shown for comparison to the left on the gel in Fig. 2B . Competitive binding assays with the native mouse Klf9 T 3 RE showed a DNA binding affinity in the low nanomolar range (ϳ5 nM), whereas a mutated mKlf9 T 3 RE (see supplemental Table 2 ) did not displace the radiolabeled probe (Fig. 2C) . TR␤-RXR heterodimers also bound to the upstream rat and human DR-4 T 3 REs and the mouse intronic IP-4T 3 RE (Fig. 2D) .
The Klf9 DR-4 T 3 RE supports T 3 -dependent transactivation
We tested for functionality of the mouse Klf9 DR-4 T 3 RE by transfection assay using putative T 3 RE sequences subcloned into a minimal promoter reporter plasmid (pGL3promoter). The pGL3mKlf9[DR-4T 3 RE] plasmid transfected into N2a[TR␤1] cells was activated by T 3 in a time-dependent manner, with increased luciferase expression at 6 h and maximum expression at 24 h [4.6-fold; Fig. 3A ; F (3, 21) ϭ 58.575, P Ͻ 0.0001, ANOVA]. The ptkDR-4Luc plasmid included as a positive control was similarly activated by T 3 [first significant elevation at 3 h, maximum activation at 24 h, 7.2-fold; F (3, 21) ϭ 45.105, P Ͻ 0.0001]; luciferase activity in cells transfected with empty vector (pGL3promoter) was not altered by T 3 treatment (data not shown).
In contrast to the native Klf9 DR-4T 3 RE, cells transfected with a plasmid containing the mutated mouse Klf9 DR-4T 3 RE (pGL3mKlf9[mtDR-4T 3 RE]) did not show activation of luciferase expression by T 3 treatment (for 24 h; Fig. 3B ; pGL3mKlf9[DR-4T 3 RE] 5.2-fold activation, P Ͻ 0.0001, t test; ptkDR-4Luc 8-fold activation, P Ͻ 0.0001). Cells transfected with the plasmid containing the mutant T 3 RE had a higher basal level of luciferase expression, which likely reflects the removal of the repressor activity of the unliganded TR (which represses basal activity of pGL3mKlf9[DR-4T 3 RE] in the absence of T 3 ). The putative mouse intronic IP-4T 3 RE and rat DR-4T 3 RE were also activated by T 3 , although to a lesser extent than the mouse DR-4T 3 RE (ϳ2-fold; pGL3mKlf9intronicIP-4T 3 RE: control, 10.90 Ϯ 0.54; T 3 , 25.73 Ϯ 1.81, P Ͻ 0.001, t test; pGL3rKlf9DR-4T 3 RE: control, 4.58 Ϯ 0.67, T 3 , 8.45 Ϯ 0.27, P Ͻ 0.0001); we did not test the putative human DR-4 T 3 RE in transfection assay.
TRs associate with the Klf9 DR-4 T 3 RE region in N2a[TR␤1] cells as analyzed by ChIP assay
Treatment of N2a[TR␤1] cells with T 3 caused a dose-dependent increase in Klf9 and hr mRNA levels (see supplemental (Fig. 4A) . The TR ChIP signal was significantly different from the NRS control at the DR-4 T 3 RE in untreated (P ϭ 0.033; t test) and T 3 -treated cells (P Ͻ 0.0001) but not at other regions of the Klf9 gene that included the proximal promoter, the putative intronic IP-4T 3 RE (ϳ5.2 kb downstream from the transcription start site; see Table 1 and Fig. 2A) or the medial intron (11.5 kb downstream from the transcription start site). The TR ChIP signal normalized for background (TR antibody signal minus NRS signal) was significantly greater at the DR-4 T 3 RE compared with other Klf9 gene regions in both untreated and T 3 -treated cells [F (7, 39) ϭ 17.851, P Ͻ 0.0001; ANOVA]. We also analyzed TR association with the hr DR-4 T 3 RE and found significant TR ChIP signal compared with NRS controls in both untreated (P ϭ 0.030; t test) and T 3 -treated (P ϭ 0.004) cells. Treatment with T 3 for 24 h significantly increased TR association with the Klf9 DR-4 T 3 RE (P ϭ 0.008; TR ChIP signal normalized for background); although there was a trend toward greater TR association at the hr DR-4T 3 RE on T 3 treatment this was not statistically significant.
Thyroid hormone treatment of N2a[TR␤1] cells increases acetylation of histones 3 and 4 at the Klf9 DR-4 T 3 RE
Basal levels of acetylation of histones 3 and 4 were comparable across genomic regions analyzed (Fig. 4, B and C) . Treatment of N2a[TR␤1] cells with T 3 increased acetylated histone 3 [F (7, 46) ϭ 23.078, P Ͻ 0.0001; ANOVA] and histone 4 [F (7, 46) ϭ 30.166, P Ͻ 0.0001] ChIP signals at several Klf9 genomic regions with the largest increase at the DR-4 T 3 RE (acH3, 3.3-fold; acH4, 5.9-fold). There was no significant change in either AcH3 or acH4 at the proximal promoter region. Similar increases were observed at the hr DR-4 T 3 RE region (acH3, 2.7-fold; acH4, 3.3-fold; P Ͻ 0.0001 for both; t test).
TR associates with the Klf9 DR-4 T 3 RE in neonatal mouse brain in vivo
We observed a significant TR ChIP signal when compared with NRS controls at the Klf9 DR-4 T 3 RE in both hippocampus (NRS ϭ 0.07%, TR ϭ 0.17%, P ϭ 0.008; t test) and cerebellum (P ϭ 0.01; Fig. 5A ) of neonatal mice. No significant TR ChIP signal was observed at the proximal promoter, proximal intron, or medial intron (only cerebellum analyzed). By contrast, we did not detect TR ChIP signal at the hr DR-4T 3 RE (data not shown).
We found significant acH4 ChIP signal compared with NRS controls at each region of the mouse Klf9 gene except at the medial intron in hippocampus and cerebellum (P Ͻ 0.05; t tests; Fig. 5 , B and C; only acH4 was analyzed due to limitation in the amount of available chromatin). There were significant differences in normalized acH4 ChIP signal across the Klf9 gene in both hippocampus [F (3, 15) ϭ 4.361, P ϭ 0.027] and cerebellum [F (3, 15) ϭ 4.167, P ϭ 0.031] with the highest signal at the Klf9 DR-4 T 3 RE. A similar high level of acH4 signal was observed at the hr DR-4 T 3 RE in both brain regions (acH4 vs. NRS: hippocampus, P ϭ 0.01; cerebellum, P ϭ 0.029; t test).
Discussion
We identified a T 3 RE of the DR-4 type at 3.8 kb upstream of the transcription start site of the mouse Klf9 gene to explain its regulation by thyroid hormone. TR-RXR heterodimers bound to the mouse DR-4 T 3 RE with high affinity in vitro, and the sequence supported T 3 -dependent transactivation in transfection assays. Furthermore, ChIP assays showed that TRs associated with this T 3 RE in the mouse-derived cell line N2a[TR␤1] and neonatal mouse brain in vivo, and treatment with T 3 led to hyperacetylation of histones at this site. We also provide further evidence that the DR-4 T 3 RE discovered in mammalian hr genes [at ϳ2 kb upstream of the transcription start site in mouse, ϳ2.6 kb in rat and human; Engelhard and Christiano (39)] is a bona fide hormone response element. 
org
Krü ppel-like factor 9 promotes differentiation of mammalian and amphibian neuronal cells, mediating T 3 actions on neurite extension and branching (13) (14) (15) . Disruption of the Klf9 gene in mouse led to behavioral abnormalities characteristic of defects in the hippocampus, cerebellum, and amygdala and reduced dendritic arborization of cerebellar Purkinje cells (16) . The Klf9 gene was isolated as a direct T 3 response gene in the frog (11, 31) , and we showed that rat Klf9 is also regulated by T 3 and exhibits a rise in expression in the brain beginning in the neonatal period (13) . Similar to our findings in rat brain, here we report that mouse Klf9 is developmentally regulated, with postnatal expression in both the hippocampus and cerebellum increasing up to 30 d of age, paralleling the postnatal rise in plasma T 3 (1) . Injection of T 3 into P4 mice elevated Klf9 mRNA in the hippocampus and cerebellum, which supports our findings in the rat that the postnatal rise in Klf9 expression is dependent on thyroid hormone (13) .
The rapid kinetics of Klf9 up-regulation by T 3 in N2a[TR␤1] cells, the fact that T 3 induction of Klf9 mRNA is resistant to protein synthesis inhibition, and the fact that nuclear run-on assay showed that T 3 initiates Klf9 transcription (13) suggested that mouse Klf9 is a direct T 3 response gene. Furlow and Kanamori (18) provided evidence for a DR-4 T 3 RE located about 6.5 kb upstream of the transcription start site of the frog Klf9 gene. We therefore searched for T 3 REs in the mouse Klf9 gene to explain its regulation by T 3 . TRs bind to DNA at the consensus hexamer sequence (G/A)GGT(C/G)A, referred to as a half-site because TRs function predominantly as dimers. Most known T 3 REs are comprised of two half-sites that are arrayed as either direct repeats spaced by four nucleotides (DR-4), IPs spaced by four to six nucleotides or palindromes (Pal) (reviewed in Ref. 24) . TRs can bind to T 3 REs as monomers or homodimers, but the preferred configuration is a heterodimer with RXR (24), Table 2 ). The TR ChIP signals at the Klf9 DR-4T 3 RE and the hr DR-4 T 3 RE were significantly increased by T 3 treatment. Treatment with thyroid hormone causes hyper-acH3 (B) and -acH4 (C) in N2a[TR␤1] cells as analyzed by ChIP assay. NSB was assessed by ChIP using NRS (A) or IgG purified from NRS (B and C). Shown are the mean ChIP signals expressed as a percentage of the input minus the NSB. Statistical analyses were conducted on arcsine transformed data, and letters indicate significant differences among means (P Ͻ 0.05; Fisher's least squares difference test; n ϭ 6/treatment). *, Statistically significant differences (P Ͻ 0.05; Student's unpaired t test; n ϭ 6/treatment).
as we also found in our gel shift assays using the mouse Klf9 DR-4T 3 RE (see Fig. 2 ). TR-RXR heterodimers exhibit a strong preference for DR-4, and DR-4T 3 REs are the most common and best-characterized response elements (24) . Studies in the frog X. laevis using ChIP assay confirmed that TR-RXR is associated with DR-4 elements in the TR␤ and basic leucine zippertranscription factor (TH/bZip) gene promoters in vivo during tadpole metamorphosis (26) .
Using computer analysis, we identified putative T 3 REs upstream and within the mouse Klf9 gene. We chose for analysis two sequences based in part on the strong conservation of the genomic regions in which they were found among mouse, rat, and human, one at Ϫ3.8 kb and one within the intron at about ϩ5.2 kb. The Ϫ3.8 kb T 3 RE is of the type DR-4 with head-to-tail orientation of half-sites, whereas the intronic T 3 RE has the configuration of an inverted palindrome with half-sites spaced by four nucleotides (IP-4) . Other putative T 3 REs found in the upstream region or intron by computer analysis were represented by single half-sites [T 3 REs of almost all positively regulated genes are comprised of two or more half-sites; (24) ], poor matches to known T 3 REs, or were not conserved across species and thus were not studied further. We cannot rule out the possibility that other functional T 3 REs not identified by this approach that may influence Klf9 gene expression are present within, near, or far upstream or downstream of the Klf9 locus, and further study is required to test this.
We found that both putative mouse Klf9 T 3 REs were bound by TR-RXR heterodimers in gel shift assays and that both supported T 3 -dependent transactivation in transfection assay. However, whereas TR was found to be associated with the Ϫ3.8 kb DR-4 T 3 RE in both N2a[TR␤1] cells and mouse brain in vivo by ChIP assay, we found no association of TR with the putative intronic IP-4 T 3 RE region, thus failing to support that this sequence is a functional T 3 RE. This finding illustrates that, although a putative T 3 RE may be bound by TR-RXR in vitro and may support T 3 -dependent transcription in transfection assay, analysis of TR association with the genomic region in vivo by ChIP assay is necessary to test whether the element is functional. Treatment of N2a[TR␤1] cells with T 3 increased the ChIP signal at both the Klf9 and hr upstream DR-4 T 3 RE regions but not at the proximal promoter, proximal intron, or medial intron of the Klf9 gene. The increased TR signal at the upstream Klf9 DR-4 T 3 RE (and the hr DR-4T 3 RE) further supports that this region possesses a bona fide hormone response element. In the unliganded state, TRs are associated with chromatin and are not thought to be recruited to genomic sites on hormone binding as occurs for some other members of the steroid receptor superfamily (32) . By contrast, we found evidence for recruitment of TRs to T 3 REs upon hormone binding. Because the expression of TR␤1 in N2a[TR␤1] cells is maintained at a constant level through stable transfection (17) and we previously showed that T 3 -dependent Klf9 expression is mediated by TR␤1 and not TR␣1, it is unlikely that the increased TR ChIP signal was due to increased TR biosynthesis. Buchholz et al. (30) reported that TR association with the Xenopus TR␤ and basic leucine zipper transcription factor (TH/bZip) promoters in vivo was increased by treatment of tadpoles with T 3 . This increase could have been due to T 3 -dependent recruitment of TRs to genomic sites or perhaps as a result of increased TR biosynthesis, which occurs in tadpoles [TR␤ autoinduction; (33) ]. Our findings suggest that whereas TR associates with T 3 REs in the genome in the unliganded form, additional TR recruitment to T 3 REs may occur on ligand binding in vivo. An alternate explanation is that ligand binding to TR or histone modifications at the T 3 RE caused by T 3 -dependent recruitment of coregulators to this site may expose epitopes on TR, thus resulting in more efficient ChIP. Further study is required to distinguish these potential mechanisms.
FIG. 5.
A, TR associates with the mouse Klf9 DR-4 T 3 RE in neonatal mouse cerebellum as analyzed by ChIP assay. P4 mice were injected with T 3 (25 g/kg body weight) and brain tissue harvested 4 h later for chromatin extraction and ChIP assay (see Materials and Methods). acH4 is elevated at the Klf9 DR-4 T 3 RE and the hr DR-4 T 3 RE in mouse hippocampus (B) and cerebellum (C) as analyzed by ChIP assay. ChIP samples were analyzed by real-time quantitative PCR using TaqMan assays that targeted the genomic regions indicated in the graph (and supplemental see Table 2 ). Shown in the graphs are the mean ChIP signals expressed as a percentage of the input for PB anti-TR serum (anti-TR) or NRS. However, statistics were conducted on the normalized TR or acH4 ChIP values, i.e. the mean ChIP signals expressed as a percentage of the input minus the NSB. NSB was assessed by ChIP using NRS (A) or IgG purified from NRS (B and C) For anti-TR, the ChIP signal was significantly greater than for NRS only at the DR-4 T 3 RE (*, P Ͻ 0.05; Student's unpaired t test; n ϭ 4). For anti-acH4, the ChIP signal was significantly greater than for NRS IgG at all regions of the Klf9 gene except the medial intron; statistics shown in the graphs do not compare the mean anti-acH4 vs. NRS ChIP signals but instead the normalized anti-acH4 ChIP values among Klf9 gene regions (letters indicate significant differences among means; P Ͻ 0.05; Fisher's least squares difference test; n ϭ 4). Anti-acH4, Purified IgG to acetylated histone 4. The TR-RXR heterocomplex recruits coregulator proteins that mediate the repressive or activational actions of the complex by recruiting histone modifying enzymes such as histone acetyltransferases and histone deacetylases, among others (34, 35) . We observed robust increases in the acetylation of histones 3 and 4 at the upstream Klf9 DR-4T 3 RE caused by T 3 treatment in N2a[TR␤1] cells and significantly greater acH4 at the DR-4T 3 RE compared with other regions of the Klf9 gene in mouse brain in vivo. The level of histone acetylation was greatest at the upstream DR-4T 3 RE, but elevated histone acetylation caused by T 3 treatment was observed at all regions of the Klf9 locus analyzed. The widespread histone acetylation could be due to spreading of histone modifications across the genetic locus originating from the site of TR binding. Interestingly, histone acetylation at the proximal Klf9 promoter was the least affected by T 3 . Parker et al. (36) recently reported in Drosophila cells that, on activation of Wnt signaling, acetylation of histones 3 and 4 spread over relatively large genomic regions occupied by the Wnt target genes naked cuticle and Notum, with relatively small changes occurring at the promoter regions of these genes. By contrast, histone acetylation was restricted to the promoter regions of housekeeping genes that were not activated by Wnt. Whether such spread of histone acetylation, with the hormone response element acting as a nucleation site, is a characteristic of hormone-responsive genes requires further study.
The hr gene encodes a zinc-finger domain transcription factor that interacts with TRs and function as a corepressor (37, 38) . The hr mRNA exhibited developmental stage and T 3 -dependent regulation in mouse brain similar to that of Klf9. Also, we found TR association and T 3 -dependent histone acetylation with the predicted hr DR-4T 3 RE located at about Ϫ2 kb. Although we found TR association with the hr DR-4T 3 RE in N2a[TR␤1] cells, we were unable to confirm this in mouse brain in vivo. Thus, our evidence supports that the mouse hr gene has a functional T 3 RE at about 2 kb upstream of the transcription start site, but further study is required to elucidate its role in mouse brain in vivo.
Taken together, our findings support the presence of a functional DR-4 T 3 RE at 3.8 kb upstream of the transcription start site of the mouse Klf9 gene to explain its regulation by T 3 during early postnatal life. We also provide evidence that this T 3 RE may be evolutionarily conserved among mammals. We found that TRs may be recruited to chromatin on ligand binding, and future studies should analyze dynamic changes in TR recruitment, corepressor/coactivator exchange, and histone modifications at the mouse Klf9 gene and other T 3 -responsive genes in vivo.
